Impact of extrafine formulation single-inhaler triple therapy on lung function after three months of treatment in patients with asthma: the TriMaximize study

被引：1

作者：

Gessner, Christian ^{[1
]}

Akyildiz, Berktan ^{[2
]}

Russell, Richard ^{[3
]}

Nachtigall, Detlef ^{[2
]}

Ulrik, Charlotte Suppli ^{[4
]}

Bogoevska, Valentina ^{[2
]}

Pohl, Wolfgang ^{[5
]}

Licht, Bjoern ^{[2
]}

Criee, Carl-Peter ^{[6
]}

机构：

[1] Pneumol Praxis Leipzig, Leipzig, Germany

[2] Chiesi GmbH Hamburg, Hamburg, Germany

[3] Univ Oxford, Oxford, England

[4] Copenhagen Univ Hosp Hvidovre, Dept Pulm Med, Hvidovre, Denmark

[5] Vienna Healthcare Grp, Karl Landsteiner Inst Clin & Expt Pneumol, Clin Hietzing, Vienna, Austria

[6] Praxis Innere Med & Pneumol, Northeim, Germany

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷

关键词：

D O I：

10.1183/13993003.congress-2023.PA2379

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：3

共 50 条

[21] Improvement of treatment adherence after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
Gessner, C.
Akyildiz, B.
Grickschat, V
Borucki, T.
Trinkmann, F.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[22] The Use of Inflammation Parameters in the Care of Patients with Asthma Prescribed Extrafine Single-Inhaler Triple Therapy: A Real-World View from Germany
Gessner, C.
Akyildiz, B.
Nachtigall, D.
Nudo, E.
Boeing, S.
Timmermann, H.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[23] COST-EFFECTIVENESS OF SINGLE-INHALER EXTRAFINE BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRRONIUM VS OTHER OPEN OR SINGLE-INHALER TRIPLE THERAPIES IN ADULT PATIENTS WITH UNCONTROLLED ASTHMA IN ENGLAND
Orlovic, M.
Tzelis, D.
Guerra, I
Madoni, A.
VALUE IN HEALTH, 2023, 26 (12) : S128 - S129
[24] Change in health-related quality of life after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
Koczulla, A.
Akyildiz, B.
Slawinska, R.
Martini, M.
Gessner, C.
PNEUMOLOGIE, 2023, 77 : S35 - S35
[25] IMPACT Study: Cost-Effectiveness of Single-Inhaler Triple Therapy for the Treatment of COPD by Patients' Exacerbation History in Quebec
Schroeder, M.
Shah, D.
Martin, A.
Ndirangu, K.
Risebrough, N.
Ismaila, A. S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[26] TRICOP - A real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
Marth, Katharina
Renner, Andreas
Pohl, Wolfgang
WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 616 - 616
[27] TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
Marth, Katharina
Renner, Andreas
Pohl, Wolfgang
RESPIRATORY MEDICINE, 2021, 182
[28] Effects Of Extrafine Single Inhaler Triple Therapy On Lung Function In COPD Patients: Results From Responder Analysis From The Trinity Study
Scuri, M.
Vestbo, J.
Papi, A.
Corradi, M.
Montagna, I.
Francisco, C.
Cohuet, G.
Vezzoli, S.
Muraro, A.
Petruzzelli, S.
Singh, D.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
[29] EFFECT OF EXTRAFINE SINGLE INHALER TRIPLE THERAPY ON LUNG FUNCTION AND USE OF RESCUE MEDICATION: RESULTS FROM THE TRINITY STUDY
Scuri, M.
Vestbo, J.
Papi, A.
Corradi, M.
Montagna, I.
Francisco, C.
Cohuet, G.
Vezzoli, S.
Muraro, A.
Petruzzelli, S.
Singh, D.
THORAX, 2017, 72 : A230 - +
[30] Extrafine single inhaler triple therapy effectiveness in COPD patients previously treated with multiple-inhaler triple therapy: the TRIWIN study
Steiropoulos, Paschalis
Georgatou, Niki
Krommidas, George
Bartziokas, Konstantinos
Korkontzelou, Aliki
Katerelos, Panos
Efstathopoulos, Petros
Papapetrou, Dimosthenis
Theodorakis, Stavros
Porpodis, Konstantinos
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2024, 18

← 1 2 3 4 5 →